Jared Gollob, Chief Medical Officer: Kymera Therapeutics KYMR Planned sale · Filed 25/10/15

Trade details

Type: Planned sale notice
Stock: Kymera Therapeutics KYMR
Person: Jared GollobChief Medical Officer
Planned sale date: 25/10/15
Filed: 25/10/15

More to sell after $186.8K in 3 months

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/15~25/11/14

Jared Gollob's recent trades

Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$273.3K
3,048 sh
$273.3K
Filed 03/04
Traded 03/02
Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$214.2K
2,519 sh
$214.2K
Filed 03/04
Traded 03/04
Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$132.5K
1,510 sh
$132.5K
Filed 03/04
Traded 03/02
Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$123.3K
1,437 sh
$123.3K
Filed 03/04
Traded 03/04
Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$93.4K
1,055 sh
$93.4K
Filed 03/04
Traded 03/02

Jared Gollob, Chief Officer — plans to sell 59,576 sh of Kymera Therapeutics KYMR · $3.5M · around 10/15 · 10b5-1 plan | Whalegun